Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway

The Lancet Oncology

Volumn 10, Issue 5, 2009, Pages 481-488

  Hemminki, Kari ^a,b   Tretli, Steinar ^c   Sundquist, Jan ^d,e   Johannesen, Tom B ^c   Granström, Charlotta ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c CANCER REGISTRY OF NORWAY   (Norway)

^d LUND UNIVERSITY   (Sweden)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHILD; CONTROLLED STUDY; EPENDYMOMA; FAMILIAL CANCER; FAMILY HISTORY; GENETIC RISK; HEMANGIOMA; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; MENINGIOMA; NERVOUS SYSTEM TUMOR; NEURINOMA; NEUROBLASTOMA; NORWAY; ONSET AGE; PARENT; PENETRANCE; PRIORITY JOURNAL; RECESSIVE INHERITANCE; SIBLING; SWEDEN;

ADULT; AGE OF ONSET; AGED; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MIDDLE AGED; NERVOUS SYSTEM NEOPLASMS; NORWAY; PARENTS; SIBLINGS; SWEDEN; YOUNG ADULT;

EID: 65349119958     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70076-2     Document Type: Article

References (40)

1. In: Louis D.N., Oghaki H., Wiestler O.D., and Cavenee W. (Eds). WHO classification of tumors of the central nervous system (2007), IARC Press, Lyon
2. Bondy M.L., Scheurer M.E., Malmer B., et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113 7 suppl (2008) 1953-1968
3. In: Stewart B., and Kleihues P. (Eds). World cancer report (2003), IARC Press, Lyon
4. Hemminki K., Lenner P., Sundquist J., and Bermejo J.L. Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis. J Clin Oncol 26 (2008) 1850-1857
5. Hijiya N., Hudson M.M., Lensing S., et al. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA 297 (2007) 1207-1215
6. Maule M., Scelo G., Pastore G., et al. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. J Natl Cancer Inst 99 (2007) 790-800
7. Hemminki K., Sundquist J., and Lorenzo Bermejo J. How common is familial cancer. Ann Oncol 19 (2008) 163-167
8. Goldgar D.E., Easton D.F., Cannon-Albright L.A., and Skolnick M.H. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86 (1994) 1600-1607
9. Malmer B., Grönberg H., Bergenheim A., Lenner P., and Henriksson R. Familial aggregation of astrocytoma in northern Sweden: an epidemiological cohort study. Int J Cancer 81 (1999) 366-370
10. Malmer B., Iselius L., Holmberg E., Collins A., Henriksson R., and Gronberg H. Genetic epidemiology of glioma. Br J Cancer 84 (2001) 429-434
11. Hemminki K., Vaittinen P., and Kyyrönen P. Age-specific familial risks in common cancers of the offspring. Int J Cancer 78 (1998) 172-175
12. Hemminki K., Li X., and Collins V. Parental cancer as a risk factor for brain tumors (Sweden). Cancer Causes Control 12 (2001) 195-199
13. Paunu N., Pukkala E., Laippala P., et al. Cancer incidence in families with multiple glioma patients. Int J Cancer 97 (2002) 819-822
14. Malmer B., Henriksson R., and Gronberg H. Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma. Neuroepidemiology 21 (2002) 279-286
15. Hemminki K., and Li X. Familial risks in nervous system tumors. Cancer Epidemiol Biomarkers Prev 12 (2003) 1137-1142
16. Blumenthal D.T., and Cannon-Albright L.A. Familiality in brain tumors. Neurology 71 (2008) 1015-1020
17. O'Neill B.P., Blondal H., Yang P., et al. Risk of cancer among relatives of patients with glioma. Cancer Epidemiol Biomarkers Prev 11 (2002) 921-924
18. Olsen J.H., Boice J.D., Seersholm N., Bautz A., and Fraumeni J.J.F. Cancer in the parents of children with cancer. N Engl J Med 333 (1995) 1594-1599
19. Winther J.F., Sankila R., Boice J.D., et al. Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study. Lancet 358 (2001) 711-717
20. Searles Nielsen S., Mueller B.A., Preston-Martin S., et al. Family cancer history and risk of brain tumors in children: results of the SEARCH international brain tumor study. Cancer Causes Control 19 (2008) 641-648
21. Hemminki K., Li X., Plna K., Granström C., and Vaittinen P. The nation-wide Swedish Family-Cancer Database: updated structure and familial rates. Acta Oncol 40 (2001) 772-777
22. Centre for Epidemiology. Cancer incidence in Sweden 2005 (2007), National Board of Health and Welfare, Stockholm
23. Cancer Registry of Norway. Cancer in Norway 2007-Cancer incidence, mortality, survival and prevalence in Norway (2008), Cancer Registry of Norway, Oslo
24. Esteve J., Benhamou E., and Raymond L. Statistical methods in cancer research (1994), IARC Press, Lyon
25. Hemminki K., Vaittinen P., Dong C., and Easton D. Sibling risks in cancer: clues to recessive or X-linked genes?. Br J Cancer 84 (2001) 388-391
26. Breslow N.E., and Day N.E. Statistical methods in cancer research. Volume II - the design and analysis of cohort studies. IARC Sci Publ 82 (1987) 1-406
27. Johannesen T.B., Angell-Andersen E., Tretli S., Langmark F., and Lote K. Trends in incidence of brain and central nervous system tumors in Norway, 1970-1999. Neuroepidemiology 23 (2004) 101-109
28. Dreifaldt A., Carlberg M., and Hardell L. Increasing incidence rates of childhood malignant diseases in Sweden during the period 1960-1998. Eur J Cancer 40 (2004) 1351-1360
29. Raaschou-Nielsen O., Sorensen M., Carstensen H., et al. Increasing incidence of childhood tumours of the central nervous system in Denmark, 1980-1996. Br J Cancer 95 (2006) 416-422
30. Li F. Phenotypes, genotypes, and interventions for hereditary cancers. Cancer Epidemiol Biomarkers Prev 4 (1995) 579-582
31. Fearon E.R. Human cancer syndromes: clues to the origin and nature of cancer. Science 278 (1997) 1043-1050
32. Huson S. Neurofibromatosis type 1: historical perspective and introductory overview. In: Upadhyaya M., and Cooper D. (Eds). Neurofibromatosis type 1 (1998), BIOS, Oxford 1-20
33. Narod S., Stiller C., and Lenoir G. An estimate of the heritable fraction of childhood cancer. Br J Cancer 63 (1991) 993-999
34. Friedrich C. Von Hippel-Lindau syndrome. A pleomorphic condition. Cancer 86 (1999) 2478-2482
35. Hemminki K., Li X., and Collins V. A population-based study of familial central nervous system hemangioblastomas. Neuroepidemiol 20 (2001) 257-261
36. Sankila R., Olsen J.H., Anderson H., et al. Risk of cancer among offspring of childhood-cancer survivors. N Engl J Med 338 (1998) 1339-1344
37. Friedman D.L., Kadan-Lottick N.S., Whitton J., et al. Increased risk of cancer among siblings of long-term childhood cancer survivors: a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev 14 (2005) 1922-1927
38. De Rosa M., Fasano C., Panariello L., et al. Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene. Oncogene 19 (2000) 1719-1723
39. Longo L., Tonini G.P., Ceccherini I., and Perri P. Oligogenic inheritance in neuroblastoma. Cancer Lett 228 (2005) 65-69
40. Mosse Y.P., Laudenslager M., Longo L., et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455 (2008) 930-935